(Q48447146)

11 February 2018

title

Assessment of the bioactivity of antibodies against beta-amyloid peptide in vitro and in vivo (English)

1 reference

11 February 2018

1 reference

M Hasan Mohajeri

1

1 reference

11 February 2018

Meret N M Gaugler

2

1 reference

11 February 2018

Julia Martinez

3

1 reference

11 February 2018

Jay Tracy

4

1 reference

11 February 2018

Hong Li

5

1 reference

11 February 2018

Arames Crameri

6

1 reference

11 February 2018

Katrin Kuehnle

7

1 reference

11 February 2018

M Axel Wollmer

8

1 reference

11 February 2018

Roger M Nitsch

9

1 reference

11 February 2018

publication date

1 January 2004

1 reference

11 February 2018

Neurodegenerative Diseases

published in

1 reference

11 February 2018

volume

1

1 reference

11 February 2018

issue

4-5

1 reference

11 February 2018

page(s)

160-167

1 reference

11 February 2018

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

21 January 2018

1 reference

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

21 January 2018

1 reference

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation

21 January 2018

1 reference

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease

21 January 2018

1 reference

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

21 January 2018

1 reference

Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration

21 January 2018

1 reference

Cerebral hemorrhage after passive anti-Abeta immunotherapy

21 January 2018

1 reference

Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice

21 January 2018

1 reference

Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning

21 January 2018

1 reference

Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants

21 January 2018

1 reference

Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice

21 January 2018

1 reference

Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo

21 January 2018

1 reference

A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage

21 January 2018

1 reference

Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia.

21 January 2018

1 reference

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor

21 January 2018

1 reference

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

21 January 2018

1 reference

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

21 January 2018

1 reference

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

Active immunization of mice with an Abeta-Hsp70 vaccine.

21 January 2018

1 reference

beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology

21 January 2018

1 reference

release_lljrrwdzsvgc5i6djr4ijdntza

21 January 2018

Identifiers

DOI

10.1159/000080981

0 references

Fatcat ID

0 references

1 reference

11 February 2018